Moumita Bose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Moumita Bose has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Golam Moula
Research Center for Materials Science Nagoya University Furo-cho, Chikusa-ku Nagoya 464-8602 Japan
2 shared publications - Sabyasachi Sarkar
Department of Chemistry, Indian Institute of Engineering Science and Technology, Howrah-711103, India
2 shared publications - Aleksandr Stotland
Advanced Clinical Biosystems Research institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048
1 shared publication - Ameerunisha Begum
Department of Chemistry, Faculty of Science, Jamia Hamdard University, New Delhi, India
1 shared publication Brianna Simental
Kao Autoimmunity Institute and Division of Rheumatology Cedars‐Sinai Medical Center Los Angeles CA USA
1 shared publication- Caroline A. Jefferies
Kao Autoimmunity Institute, Cedars‐Sinai Medical Center, Los Angeles, California, and Division of Rheumatology, Department of Medicine, Cedars Sinai Medical Center Los Angeles
1 shared publication
Latest Publications
- Open Access
- 11 January 2024
- Published by Wiley in Arthritis & Rheumatology
- Vol. 76 (3) , 396-410
α‐Ketoglutarate–Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus
Objective: We aimed to investigate the hypothesis that interferon (IFN)–stimulated gene (ISG) expression in systemic lupus erythematosus (SLE) monocytes is linked to changes in metabolic reprogramming and epigenetic regulation of ISG expression.Methods: Monocytes from healthy volunteers and patients with SLE at baseline or following IFNα treatment were analyzed by extracellular flux analysis, proteomics, metabolomics, chromatin immunoprecipitation, and gene expression. The histone demethylases KDM6A/B were inhibited using glycogen synthase kinase J4 (GSK‐J4). GSK‐J4 was tested in pristane and resiquimod (R848) models of IFN‐driven SLE.Results: SLE monocytes had enhanced rates of glycolysis and oxidative phosphorylation compared to healthy control monocytes, as well as increased levels of isocitrate dehydrogenase and its product, α‐ketoglutarate (α‐KG). Because α‐KG is a required cofactor for histone demethylases KDM6A and KDM6B, we hypothesized that IFNα may be driving “trained immune” responses through altering histone methylation. IFNα priming (day 1) resulted in a sustained increase in the expression of ISGs in primed cells (day 5) and enhanced expression on restimulation with IFNα. Importantly, decreased H3K27 trimethylation was observed at the promoters of ISGs following IFNα priming. Finally, GSK‐J4 (KDM6A/B inhibitor) resulted in decreased ISG expression in SLE patient monocytes, as well as reduced autoantibody production, ISG expression, and kidney pathology in R848‐treated BALB/c mice.Conclusion: Our study suggests long‐term IFNα exposure alters the epigenetic regulation of ISG expression in SLE monocytes via changes in immunometabolism, a mechanism reflecting trained immunity to type I IFN. Importantly, it opens the possibility that targeting histone‐modifying enzymes, such as KDM6A/B, may reduce IFN responses in SLE. image
- 11 January 2024
- Published by Wiley in Arthritis & Rheumatology
- Vol. 76 (3) , 396-410
Open Accessα‐Ketoglutarate–Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus
Objective: We aimed to investigate the hypothesis that interferon (IFN)–stimulated gene (ISG) expression in systemic lupus erythematosus (SLE) monocytes is linked to changes in metabolic reprogramming and epigenetic regulation of ISG expression.Methods: Monocytes from healthy volunteers and patients with SLE at baseline or following IFNα treatment were analyzed by extracellular flux analysis, proteomics, metabolomics, chromatin immunoprecipitation, and gene expression. The histone demethylases KDM6A/B were inhibited using glycogen synthase kinase J4 (GSK‐J4). GSK‐J4 was tested in pristane and resiquimod (R848) models of IFN‐driven SLE.Results: SLE monocytes had enhanced rates of glycolysis and oxidative phosphorylation compared to healthy control monocytes, as well as increased levels of isocitrate dehydrogenase and its product, α‐ketoglutarate (α‐KG). Because α‐KG is a required cofactor for histone demethylases KDM6A and KDM6B, we hypothesized that IFNα may be driving “trained immune” responses through altering histone methylation. IFNα priming (day 1) resulted in a sustained increase in the expression of ISGs in primed cells (day 5) and enhanced expression on restimulation with IFNα. Importantly, decreased H3K27 trimethylation was observed at the promoters of ISGs following IFNα priming. Finally, GSK‐J4 (KDM6A/B inhibitor) resulted in decreased ISG expression in SLE patient monocytes, as well as reduced autoantibody production, ISG expression, and kidney pathology in R848‐treated BALB/c mice.Conclusion: Our study suggests long‐term IFNα exposure alters the epigenetic regulation of ISG expression in SLE monocytes via changes in immunometabolism, a mechanism reflecting trained immunity to type I IFN. Importantly, it opens the possibility that targeting histone‐modifying enzymes, such as KDM6A/B, may reduce IFN responses in SLE. image
- 29 April 2019
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 43 (21) , 8332-8340
Structurally characterized one oxo–desoxo bridged Mo2–bis(dithiolene) complex and its interconversion to a discrete oxo or desoxo DMSOR model
A new molybdenum complex, [Et4N]2[Mo(PPh3)(mnt)2–OMo(mnt)2]·CH2Cl2·½H2O (1, mnt = maleonitrile dithiolene = S2C2(CN)2), with unique structural features was synthesized, in which the fragment {Mo(PPh3)(mnt)2–} was attached to another important {–OMo(mnt)2} moiety. The structure of 1 was formed by the association of both the oxo and desoxo motifs of the dimethylsulfoxide reductase (DMSOR) class of enzymes. This dissymmetrical binuclear complex 1 is rare, and it utilized the basic inorganic aspects to accommodate both moieties; under basic conditions, it was converted to (Et4N)2[MoO(mnt)2] (2). Similarly, when treated with PhSH and PPh3, it was completely converted to [Et4N]2[Mo(PPh3)(mnt)2(SPh)] (3) (J. Am. Chem. Soc., 2006, 128, 4196–4197). The chemistry of 1 was analyzed with regard to its synthesis, reactivity, crystal structure, and spectroscopic and photophysical properties. In addition, the results were complemented with DFT calculations.
- 29 April 2019
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 43 (21) , 8332-8340
Structurally characterized one oxo–desoxo bridged Mo2–bis(dithiolene) complex and its interconversion to a discrete oxo or desoxo DMSOR model
A new molybdenum complex, [Et4N]2[Mo(PPh3)(mnt)2–OMo(mnt)2]·CH2Cl2·½H2O (1, mnt = maleonitrile dithiolene = S2C2(CN)2), with unique structural features was synthesized, in which the fragment {Mo(PPh3)(mnt)2–} was attached to another important {–OMo(mnt)2} moiety. The structure of 1 was formed by the association of both the oxo and desoxo motifs of the dimethylsulfoxide reductase (DMSOR) class of enzymes. This dissymmetrical binuclear complex 1 is rare, and it utilized the basic inorganic aspects to accommodate both moieties; under basic conditions, it was converted to (Et4N)2[MoO(mnt)2] (2). Similarly, when treated with PhSH and PPh3, it was completely converted to [Et4N]2[Mo(PPh3)(mnt)2(SPh)] (3) (J. Am. Chem. Soc., 2006, 128, 4196–4197). The chemistry of 1 was analyzed with regard to its synthesis, reactivity, crystal structure, and spectroscopic and photophysical properties. In addition, the results were complemented with DFT calculations.
- 31 March 2011
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 50 (9) , 3852-3854
Dangling Thiyl Radical: Stabilized in [PPh4]2[(bdt)WVI(O)(μ-S)2CuI(SC6H4S•)]
The synthesis, crystal structure, and spectroscopic characterization of [PPh4]2[(bdt)W(O)(S2)Cu(SC6H4S•)] (3; bdt = benzenedithiolate) relevant to the active site of carbon monoxide dehydrogenase are presented. Curiously, in 3, the copper(I) benzenemonothiolate subcenter possesses a dangling thiyl radical that is stabilized by a disulfido-bridged oxo tungsten dithiolene core. The benzenedithiolate ligand, which is generally bidentate in nature, acts as a bidentate and also as a monodentate in 3. The formation of an unusual dangling thiyl radical has been magnetically and spectroscopically identified and has been supported by the density functional theory level of calculation.
- 31 March 2011
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 50 (9) , 3852-3854
Dangling Thiyl Radical: Stabilized in [PPh4]2[(bdt)WVI(O)(μ-S)2CuI(SC6H4S•)]
The synthesis, crystal structure, and spectroscopic characterization of [PPh4]2[(bdt)W(O)(S2)Cu(SC6H4S•)] (3; bdt = benzenedithiolate) relevant to the active site of carbon monoxide dehydrogenase are presented. Curiously, in 3, the copper(I) benzenemonothiolate subcenter possesses a dangling thiyl radical that is stabilized by a disulfido-bridged oxo tungsten dithiolene core. The benzenedithiolate ligand, which is generally bidentate in nature, acts as a bidentate and also as a monodentate in 3. The formation of an unusual dangling thiyl radical has been magnetically and spectroscopically identified and has been supported by the density functional theory level of calculation.